Skip to content

Clinical trials

Phase 2 Hepatitis C trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 2 Country / region: France Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20053
20071
20097
201011
20115
20124
20132
20144
20152
20161
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Withdrawn2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb10
Gilead Sciences8
ANRS, Emerging Infectious Diseases7
Debiopharm International SA3
GlaxoSmithKline2
Tibotec Pharmaceuticals, Ireland2
Vertex Pharmaceuticals Incorporated2
AbbVie (prior sponsor, Abbott)1
Astellas Pharma Inc1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C43
Hepatitis C, Chronic9
HIV Infections3
Fibrosis2
Hepatitis2
Infections2
Liver Diseases2
Chronic Pain1
Hypertension, Portal1
Liver Cirrhosis, Experimental1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.